Annual Cash & Cash Equivalents
$133.52 M
-$43.25 M-24.47%
December 31, 2023
Summary
- As of February 7, 2025, SANA annual cash & cash equivalents is $133.52 million, with the most recent change of -$43.25 million (-24.47%) on December 31, 2023.
- During the last 3 years, SANA annual cash & cash equivalents has risen by +$8.71 million (+6.98%).
- SANA annual cash & cash equivalents is now -47.23% below its all-time high of $253.03 million, reached on December 31, 2021.
Performance
SANA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$127.00 M
-$7.96 M-5.90%
September 30, 2024
Summary
- As of February 7, 2025, SANA quarterly cash and cash equivalents is $127.00 million, with the most recent change of -$7.96 million (-5.90%) on September 30, 2024.
- Over the past year, SANA quarterly cash and cash equivalents has dropped by -$6.52 million (-4.88%).
- SANA quarterly cash and cash equivalents is now -83.08% below its all-time high of $750.69 million, reached on March 31, 2021.
Performance
SANA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SANA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.5% | -4.9% |
| 3 y3 years | +7.0% | -70.7% |
| 5 y5 years | +335.9% | - |
SANA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.2% | at low | -49.8% | at low |
| 5 y | 5-year | -47.2% | +66.8% | -83.1% | +58.7% |
| alltime | all time | -47.2% | +335.9% | -83.1% | +58.7% |
Sana Biotechnology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $127.00 M(-5.9%) |
| Jun 2024 | - | $134.96 M(-23.8%) |
| Mar 2024 | - | $177.05 M(+32.6%) |
| Dec 2023 | $133.52 M(-24.5%) | $133.52 M(-20.7%) |
| Sep 2023 | - | $168.45 M(-3.1%) |
| Jun 2023 | - | $173.79 M(+8.3%) |
| Mar 2023 | - | $160.46 M(-9.2%) |
| Dec 2022 | $176.76 M | $176.76 M(+8.2%) |
| Sep 2022 | - | $163.34 M(-16.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $194.66 M(+3.3%) |
| Mar 2022 | - | $188.52 M(-25.5%) |
| Dec 2021 | $253.03 M(+102.7%) | $253.03 M(-41.7%) |
| Sep 2021 | - | $433.67 M(-35.8%) |
| Jun 2021 | - | $675.14 M(-10.1%) |
| Mar 2021 | - | $750.69 M(+501.5%) |
| Dec 2020 | $124.81 M(+55.9%) | $124.81 M(-16.4%) |
| Sep 2020 | - | $149.22 M(+86.5%) |
| Dec 2019 | $80.03 M(+161.3%) | $80.03 M |
| Dec 2018 | $30.63 M | - |
FAQ
- What is Sana Biotechnology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sana Biotechnology?
- What is Sana Biotechnology annual cash & cash equivalents year-on-year change?
- What is Sana Biotechnology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Sana Biotechnology?
- What is Sana Biotechnology quarterly cash and cash equivalents year-on-year change?
What is Sana Biotechnology annual cash & cash equivalents?
The current annual cash & cash equivalents of SANA is $133.52 M
What is the all time high annual cash & cash equivalents for Sana Biotechnology?
Sana Biotechnology all-time high annual cash & cash equivalents is $253.03 M
What is Sana Biotechnology annual cash & cash equivalents year-on-year change?
Over the past year, SANA annual cash & cash equivalents has changed by -$43.25 M (-24.47%)
What is Sana Biotechnology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SANA is $127.00 M
What is the all time high quarterly cash and cash equivalents for Sana Biotechnology?
Sana Biotechnology all-time high quarterly cash and cash equivalents is $750.69 M
What is Sana Biotechnology quarterly cash and cash equivalents year-on-year change?
Over the past year, SANA quarterly cash and cash equivalents has changed by -$6.52 M (-4.88%)